Showing results (111-120 of 357) with videos related to

Sort By:
Pageof 36
Antiviral Chemistry & Chemotherapy|December 10, 2013
Therapy for latent HIV-1 infection: the role of histone deacetylase inhibitorsMary E Manson McManamy, Shweta Hakre, Eric M Verdin, et al.
European Journal of Medicinal Chemistry|February 27, 2022
Development of small molecules that work cooperatively with ciprofloxacin to clear salmonella biofilms in a chronic gallbladder carriage modelKatherine J Woolard, Jenna L Sandala, Roberta J Melander, et al.
ACS Infectious Diseases|November 17, 2018
Using Small-Molecule Adjuvants to Repurpose Azithromycin for Use against Pseudomonas aeruginosaVeronica B Hubble, Brittany A Hubbard, Bradley M Minrovic, et al.
Science (New York, N.Y.)|July 28, 2016
Latency reversal and viral clearance to cure HIV-1David M Margolis, J Victor Garcia, Daria J Hazuda, et al.
Bioorganic & Medicinal Chemistry Letters|November 24, 2016
Marine sponge alkaloids as a source of anti-bacterial adjuvantsRoberta J Melander, Hong-Bing Liu, Matthew D Stephens, et al.
Bioorganic & Medicinal Chemistry|March 23, 2019
Tryptamine derivatives disarm colistin resistance in polymyxin-resistant gram-negative bacteriaWilliam T Barker, Courtney E Chandler, Roberta J Melander, et al.
Marine Drugs|November 11, 2011
Anti-biofilm compounds derived from marine spongesSean D Stowe, Justin J Richards, Ashley T Tucker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 22, 2008
Improved measures of quality of life, lipid profile, and lipoatrophy after treatment interruption in HIV-infected patients with immune preservation: results of ACTG 5170Daniel J Skiest, Amy Krambrink, Zhaohui Su, et al.
Cell Reports|October 4, 2018
Single-Cell Analysis of Quiescent HIV Infection Reveals Host Transcriptional Profiles that Regulate Proviral LatencyTodd Bradley, Guido Ferrari, Barton F Haynes, et al.
Pageof 36